Objective To compare the efficacy of covid-19 vaccines between immunocompromised and
immunocompetent people. Design Systematic review and meta-analysis. Data sources …

Objectives Available data show that COVID-19 vaccines may be less effective in people
living with HIV (PLWH) who are at increased risk for severe COVID-19. This meta-analysis …

Abstract The SARS-CoV-2 Omicron variant has very high levels of transmission, is resistant
to neutralization by authorized therapeutic human monoclonal antibodies (mAb) and is less …

The detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–specific
antibodies in the serum of an individual indicates previous infection or vaccination …

Research on coronavirus disease 2019 vaccination in immune-deficient/disordered people
(IDP) has focused on cancer and organ transplantation populations. In a prospective cohort …

Control of the ongoing SARS-CoV-2 pandemic is endangered by the emergence of viral
variants with increased transmission efficiency, resistance to marketed therapeutic …

Although the chief of the World Health Organization (WHO) has declared the end of the
coronavirus disease 2019 (COVID-19) as a global health emergency, the disease is still a …

Background and objective The fourth dose the COVID-19 vaccine was first proposed to
immunocompromised patients. The aim of the article is to systematically review the literature …

Simple Summary The COVID-19 pandemic has had a significant impact on health care
including cancer screening. We examined 2020 compared to the 2014–2019 cancer …

The human gut microbiome interacts with many diseases, with recent small studies
suggesting a link with COVID-19 severity. Exploring this association at the population-level …